Publication Ethics

Journal Information

Publication Ethics

Biotechnology Frontiers: An International Journal ISSN 3117-5791 is firmly committed to maintaining the highest standards of publication ethics, integrity, and transparency. The journal adheres to the Committee on Publication Ethics (COPE) guidelines to ensure fairness, accountability, and ethical responsibility at every stage of the editorial and publishing process.

The journal enforces a zero-tolerance policy toward plagiarism, data fabrication, falsification, duplicate submissions, and any other unethical research or publishing practices.

1. Ethical Responsibilities of Authors

Authors submitting manuscripts to Biotechnology Frontiers are expected to:

  • Submit original, accurate, and well-documented work free from plagiarism.
  • Properly acknowledge all sources and contributions from other researchers.
  • Avoid duplicate or redundant submission of the same work to multiple journals.
  • Disclose any conflicts of interest that may influence research outcomes or interpretation.
  • Ensure that all listed co-authors have made a significant contribution and have approved the final version.

Follow appropriate ethical standards for research involving humans, animals, cell lines, microorganisms, or genetic resources, and provide necessary ethical clearance or institutional approval when applicable.

2. Ethical Responsibilities of Reviewers

Reviewers play a crucial role in safeguarding the credibility of scholarly publishing. They are expected to:

  • Provide objective, constructive, and timely reviews that help authors improve their work.
  • Maintain strict confidentiality of the manuscript and avoid using its content for personal benefit.
  • Avoid prejudice or bias related to gender, ethnicity, religion, nationality, or institutional affiliation.
  • Declare any conflicts of interest that may compromise impartiality.
  • Report to the editorial office any suspected plagiarism, duplication, or unethical research practices.

3. Ethical Responsibilities of Editors

The editorial board, under the guidance of the Editor-in-Chief, is responsible for ensuring that:Manuscripts are evaluated based solely on academic merit, originality, and relevance to biotechnology, without discrimination.

  • The peer review process is conducted fairly, rigorously, and confidentially.
  • Conflicts of interest are avoided when making editorial or publishing decisions.
  • Allegations of misconduct are investigated promptly and transparently.
  • Retractions, corrections, or expressions of concern are issued when necessary to maintain the integrity of the scientific record.

4. Research Misconduct & Handling Procedures

The journal considers the following actions to be unethical and unacceptable:

  • Plagiarism (including self-plagiarism and improper image/data manipulation)
  • Data fabrication or falsification
  • Duplicate submission or redundant publication
  • Improper or honorary authorship attribution
  • Procedure in cases of misconduct:

The editorial office will conduct an initial investigation and request clarification from the authors.

If misconduct is confirmed, actions may include rejection, withdrawal, retraction, or publication of a correction.

In severe cases, the matter may be reported to the authors’ institution, funding agencies, or regulatory bodies.

5. Transparency and Accountability

Biotechnology Frontiers promotes openness and honesty in research practices.

All published articles undergo rigorous editorial and ethical quality checks.

Corrections, clarifications, or retractions will be published transparently in accordance with COPE standards.

6. Compliance with COPE Guidelines

The journal follows the COPE Code of Conduct for editors, reviewers, and authors. For more details, visit: https://publicationethics.org.